News

Tempers Flare Over Fate of Prostate Cancer Drug

Publish date: October 15, 2007
PDF Download

 

Activists demand FDA approval of Provenge during a Sept. 18 protest in front of the agency's offices in Rockville, Md. Sheri Mattes/Elsevier Global Medical News

Pages

Recommended Reading

Statin Use Tied to Reduced Prostate Cancer Incidence
MDedge Family Medicine
Prostate Cancer Management Varies by Specialty
MDedge Family Medicine
Single Biofeedback Session Eases Postprostatectomy Incontinence
MDedge Family Medicine
Men Don't Tell, if You Don't Ask About BPH Symptoms
MDedge Family Medicine
Eating Flaxseed May Slow Prostate Cancer Growth
MDedge Family Medicine
Bone Pain Flags Worse Survival in Prostate Cancer
MDedge Family Medicine
Quality of Life Tops List of Concerns in Prostrate Cancer
MDedge Family Medicine
Stress Coaching Eases Radical Prostatectomy Fears
MDedge Family Medicine
What is the recommended workup for a man with a first UTI?
MDedge Family Medicine
How should you further evaluate an adult with a testicular mass?
MDedge Family Medicine